These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37173237)

  • 1. New technology in prostate cancer and financial toxicity.
    Maganty A; Hollenbeck BK
    Urol Oncol; 2023 Sep; 41(9):376-379. PubMed ID: 37173237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coping Mechanisms for Financial Toxicity Among Patients With Metastatic Prostate Cancer: A Survey-based Assessment.
    Joyce DD; Schulte PJ; Kwon ED; Dusetzina SB; Moses KA; Sharma V; Penson DF; Tilburt JC; Boorjian SA
    J Urol; 2023 Aug; 210(2):290-298. PubMed ID: 37416955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial toxicity and strain among men receiving prostate cancer care in an equal access healthcare system.
    Bauer AG; Jefferson M; Nahhas GJ; Savage S; Drake R; Lilly M; Ambrose L; Caulder S; Mahvi D; Hughes Halbert C
    Cancer Med; 2020 Dec; 9(23):8765-8771. PubMed ID: 33070458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis.
    Lindsay D; Schofield P; Nabukalu D; Roberts MJ; Yaxley J; Quinn S; Richards N; Frydenberg M; Gardiner R; Lawrentschuk N; Juraskova I; Murphy DG; Gordon LG
    Aust Health Rev; 2024 Feb; 48():172-181. PubMed ID: 38342484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial toxicity associated with treatment of localized prostate cancer.
    Imber BS; Varghese M; Ehdaie B; Gorovets D
    Nat Rev Urol; 2020 Jan; 17(1):28-40. PubMed ID: 31792431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.
    Orom H; Homish DL; Homish GG; Underwood W
    Urol Oncol; 2014 May; 32(4):396-402. PubMed ID: 24332649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial Toxicity and Its Association With Prostate and Colon Cancer Screening.
    Herriges MJ; Shenhav-Goldberg R; Peck JI; Bhanvadia SK; Morgans A; Chino F; Chandrasekar T; Shapiro O; Jacob JM; Basnet A; Bratslavsky G; Goldberg H
    J Natl Compr Canc Netw; 2022 Sep; 20(9):981-988. PubMed ID: 36075394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Financial Toxicity Among United States Prostate Cancer Survivors: Results From a National Survey.
    Stone BV; Labban M; Filipas DK; Beatrici E; Frego N; Qian ZJ; Voleti SS; Lipsitz SR; Kibel AS; Trinh QD; Cole AP
    Urol Pract; 2023 Sep; 10(5):459-466. PubMed ID: 37498685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association Between Financial Toxicity and Treatment Regret in Men With Localized Prostate Cancer.
    Joyce DD; Wallis CJD; Huang LC; Hoffman KE; Zhao Z; Koyama T; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
    JNCI Cancer Spectr; 2022 Nov; 6(6):. PubMed ID: 36255249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial toxicity in prostate cancer survivors: A national cross-sectional assessment of subjective financial burden.
    Herrera CD; Guerra CE; Narayan V; Guzzo TJ; Mamtani R; Lee DJ; Tasian GE; Talwar R
    Urol Oncol; 2023 Feb; 41(2):105.e1-105.e8. PubMed ID: 36372635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial toxicity of cancer treatment in India: towards closing the cancer care gap.
    Prinja S; Dixit J; Gupta N; Dhankhar A; Kataki AC; Roy PS; Mehra N; Kumar L; Singh A; Malhotra P; Goyal A; Rajsekar K; Krishnamurthy MN; Gupta S
    Front Public Health; 2023; 11():1065737. PubMed ID: 37404274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial toxicity of oral therapies in advanced prostate cancer.
    Joyce DD; Dusetzina SB
    Urol Oncol; 2023 Sep; 41(9):363-368. PubMed ID: 37029039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral program.
    Parikh DA; Rodriguez GM; Ragavan M; Kerr E; Asuncion MK; Hansen J; Srinivas S; Fan AC; Shah S; Patel MI
    Support Care Cancer; 2024 Feb; 32(3):161. PubMed ID: 38366165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer aggressiveness and financial toxicity among prostate cancer patients.
    Kc M; Oral E; Rung AL; Trapido E; Rozek LS; Fontham ETH; Bensen JT; Farnan L; Steck SE; Song L; Mohler JL; Khan S; Vohra S; Peters ES
    Prostate; 2023 Jan; 83(1):44-55. PubMed ID: 36063402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer, screening and the generalist physician.
    Roberts RG
    J Urol; 1994 Nov; 152(5 Pt 2):1693-4. PubMed ID: 7933228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017.
    Chiong E; Murphy DG; Akaza H; Buchan NC; Chung BH; Kanesvaran R; Khochikar M; Letran J; Lojanapiwat B; Ng CF; Ong T; Pu YS; Saad M; Schubach K; Türkeri L; Umbas R; Le Chuyen V; Williams S; Ye DW; ; Davis ID
    BJU Int; 2019 Jan; 123(1):22-34. PubMed ID: 30019467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of adding cost information to a conversation aid to support shared decision making about low-risk prostate cancer treatment: Results of a stepped-wedge cluster randomised trial.
    Politi MC; Forcino RC; Parrish K; Durand MA; O'Malley AJ; Moses R; Cooksey K; Elwyn G
    Health Expect; 2023 Oct; 26(5):2023-2039. PubMed ID: 37394739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial hardship and psychosocial well-being and quality of life among prostate cancer survivors in the United States.
    Yabroff KR; Zhao J; Chen MH; Hoque J; Arias G; Han X; Zheng Z
    Urol Oncol; 2023 Sep; 41(9):380-386. PubMed ID: 37202329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient decision aids for prostate cancer treatment: a systematic review of the literature.
    Lin GA; Aaronson DS; Knight SJ; Carroll PR; Dudley RA
    CA Cancer J Clin; 2009; 59(6):379-90. PubMed ID: 19841280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial Toxicity Among Patients With Metastatic Prostate Cancer: A Mixed Methods Approach to Identify Effective Interventions.
    Joyce DD; Boehmer KR; Kamath CC; LaVecchia CM; Sharma V; Schulte PJ; Tilburt JC; Penson DF; Boorjian SA
    Urol Pract; 2024 Jul; 11(4):640-652. PubMed ID: 38899638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.